You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 31, 2025

Bulk Pharmaceutical API Sources for STERILE WATER


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for STERILE WATER

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free 195294_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 2107_SIGMA ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free W1503_SIGMA ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: Sterile Water

Last updated: July 27, 2025


Introduction

Sterile Water for Injection (SWFI) is a critical excipient used across pharmaceutical manufacturing, particularly in the preparation of injectable products. Its purity, sterility, and compliance with pharmacopoeial standards are imperative to ensure patient safety and therapeutic efficacy. Unlike active pharmaceutical ingredients (APIs) which possess therapeutic activity, sterile water is primarily an excipient and thus classified separately within manufacturing and regulatory frameworks. Nonetheless, reliable supply sources of high-quality sterile water are essential components of the pharmaceutical supply chain. This article examines the global vendors supplying bulk sterile water, their manufacturing standards, regulatory compliance, and strategic considerations for pharmaceutical companies.


Manufacturing Standards and Regulatory Frameworks

Sterile water is manufactured under stringent conditions, adhering to pharmacopoeial specifications such as USP, EP, or JP. It must be sterile, pyrogen-free, endotoxin-free, and free from particulate matter. Commonly, manufacturers employ multi-stage purification processes, including distillation, membrane filtration, and sterilization via autoclave or aseptic filtration.

Regulatory agencies mandate rigorous validation of manufacturing processes, sterility assurance levels (SAL), and batch testing. Vendors need to demonstrate compliance with current good manufacturing practices (CGMP), and their facilities often undergo regulatory inspections by authorities such as the FDA or EMA.


Leading Sources of Bulk Sterile Water

1. Fresenius Kabi

A global leader in infusion therapies, Fresenius Kabi supplies high-quality sterile water, compliant with USP, EP, and other pharmacopeias. Their manufacturing facilities in Europe, Asia, and the Americas leverage advanced distillation and sterilization technologies. Fresenius emphasizes validated aseptic processes and extensive testing, ensuring consistent product quality. The company offers bulk sterile water in various sizes, catering to both large-scale pharmaceutical manufacturing and smaller compounding needs.

2. Baxter International

Baxter produces sterile water for injections certified to stringent quality standards, with manufacturing plants worldwide. Their facilities employ multi-stage distillation, ultrafiltration, and sterilizing-grade filtration. Baxter’s sterile water products are widely used in both hospital and pharmaceutical settings, with a focus on endotoxin and pyrogen testing compliance. Their robust supply chain ensures reliable delivery to global markets.

3. B. Braun Melsungen AG

B. Braun's extensive portfolio includes sterile water for injection, prepared under rigorous GMP protocols. Their state-of-the-art manufacturing units in Europe and North America leverage advanced sterilization liaising with validated sterile filtration techniques. B. Braun’s commitment to quality management and regulatory compliance makes them a preferred supplier.

4. Hospira (a Pfizer company)

Now integrated into Pfizer, Hospira historically specialized in sterile injectable solutions and sterile water. Their manufacturing sites worldwide achieve compliance with global standards, providing bulk sterile water that meets pharmacopeial specifications. Their focus on innovation and process validation ensures high-quality supply lines.

5. local/regional manufacturers in Asia and Eastern Europe

  • Shenzhen Weikang Pharmaceutical Co., Ltd. (China): Produces sterile water via distillation and sterilizing filtration, approved by Chinese regulatory authorities and exporting globally.
  • Sina Pharmaceutical (India): Offers bulk sterile water in accordance with Indian Pharmacopoeia and international standards, with growing exports due to competitive pricing.
  • Kordia Group (Eastern Europe): Provides sterile water compliant with European standards, emphasizing rigorous validation and batch testing.

Emerging and Niche Suppliers

With the expansion of the sterile pharmaceutical market, smaller or regional manufacturers are emerging, often offering cost-competitive products tailored to local markets. Due diligence on regulatory compliance, validation history, and sterility assurance levels (SAL) is paramount when sourcing from these entities.


Key Market Considerations

Regulatory Compliance & Certification

End-users must verify that suppliers possess valid certificates of analysis, validation documentation, and regulatory approvals. Manufacturers accredited by cGMP-compliant regulatory authorities and compliant with pharmacopeial standards minimize compliance risks.

Quality Assurance & Batch Consistency

Consistent quality control, including endotoxin testing and particulate inspection, is critical. Suppliers should provide comprehensive batch testing records, sterility validation, and ongoing process monitoring.

Supply Chain Reliability

Secure partnerships with suppliers who have diversified manufacturing capacities and robust logistics networks mitigates risks of shortages or delays.

Price and Contract Flexibility

While quality is paramount, competitive pricing and flexible contract terms, including long-term supply agreements, can optimize procurement strategies.


Strategic Implications for Pharmaceutical Companies

Selecting a reliable source of sterile water is foundational to manufacturing high-quality injectable pharmaceuticals. Due diligence must encompass regulatory track record, manufacturing process validation, batch consistency, supply stability, and cost considerations. Developing partnerships with established vendors like Fresenius Kabi and Baxter, or regional manufacturers with proven compliance, can streamline supply chains and enhance product integrity.


Conclusion

Bulk sterile water remains a backbone excipient in pharmaceutical manufacturing, with a broad spectrum of suppliers spanning global giants to regional producers. Ensuring supply chain resilience requires rigorous supplier qualification processes centered on regulatory compliance, quality assurance, and manufacturing validation. In an era of stringent regulatory oversight and rising production demands, pharmaceutical companies must strategically evaluate vendors to maintain consistent, high-quality sterile water supply.


Key Takeaways

  • Reliable supply sources for sterile water are critical to pharmaceutical quality and compliance.
  • Major global suppliers include Fresenius Kabi, Baxter, B. Braun, and Pfizer’s Hospira.
  • Regulatory compliance, GMP certification, and validation documentation are non-negotiable criteria.
  • Regional suppliers offer cost benefits but require thorough qualification.
  • Strategic procurement involves balancing quality, cost, and supply chain robustness.

FAQs

1. What are the primary quality standards for sterile water production?
Sterile water must meet pharmacopeial standards (USP, EP, JP), including sterility, endotoxin limits, particulate matter standards, and non-pyrogenicity, verified through comprehensive testing.

2. How do manufacturers ensure the sterility of bulk sterile water?
Through multi-stage processes including distillation, sterilizing-grade filtration, and validated sterilization methods such as autoclaving, combined with ongoing environmental monitoring.

3. Can regional manufacturers supply sterile water compliant with international standards?
Yes, several regional producers in Asia and Eastern Europe supply pharmacopeial-compliant sterile water, provided they meet rigorous validation and quality assurance requirements.

4. What are the risks of sourcing sterile water from less-established suppliers?
Potential risks include non-compliance with regulatory standards, inconsistent quality, insufficient validation, and supply disruptions, leading to product recalls or regulatory issues.

5. How does procurement of sterile water impact pharmaceutical manufacturing in terms of regulatory approval?
Using suppliers with validated processes, proper certifications, and documentation facilitates regulatory acceptance, ensuring manufacturing processes are compliant and reducing approval delays.


Sources
[1] FDA Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing — Quality Considerations.
[2] European Pharmacopoeia, Water for Pharmaceutical Use.
[3] USP Monograph <1231> Water for Injection.
[4] International Pharmaceutical Regulators Forum (IPRF) – Sterility and Pyrogen Testing Standards.
[5] Company Websites: Fresenius Kabi, Baxter, B. Braun, Pfizer (Hospira).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.